Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.
Däublin
Gerhard
G
Lorenz-Depiereux
Bettina
B
Strom
Tim M
TM
Blankenstein
Oliver
O
Raile
Klemens
K
D019943:Amino Acid Substitution; D006580:Genetic Carrier Screening; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D016896:Treatment Outcome; D000099161:Kcnj11 Channel
D005905:Glyburide; D007004:Hypoglycemic Agents; D024661:Potassium Channels, Inwardly Rectifying; D000099161:Kcnj11 Channel